Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2011 2
2013 1
2014 2
2015 1
2016 1
2018 2
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
To explore the regulatory effect of Buyang Huanwu Decoction on cerebral infarction based on quantitative proteomics.
Li Y, Miao L, Guo R, He L, Sun M, Pan Y, Lin L, Ren J, Liu J. Li Y, et al. J Proteomics. 2023 Apr 15;277:104850. doi: 10.1016/j.jprot.2023.104850. Epub 2023 Feb 20. J Proteomics. 2023. PMID: 36813112 Clinical Trial.
Buyang Huanwu Decoction (BYHW) contains chemical components such as ligustrazine, oxypaeoniflora, chlorogenic acid, and others. ...
Buyang Huanwu Decoction (BYHW) contains chemical components such as ligustrazine, oxypaeoniflora, chlorogenic acid, and others. ...
Efficacy evaluation of Buyang Huanwu Decoction in the treatment of ischemic stroke in the recovery period: A systematic review of randomized controlled trials.
Wang R, Ren J, Li S, Bai X, Guo W, Yang S, Wu Q, Zhang W. Wang R, et al. Front Pharmacol. 2022 Oct 14;13:975816. doi: 10.3389/fphar.2022.975816. eCollection 2022. Front Pharmacol. 2022. PMID: 36313307 Free PMC article.
Background and purpose: Buyang Huanwu decoction (BYHWD) is widely used in the treatment of ischemic stroke in the recovery period, and many clinical trials have been reported, but its clinical efficacy and safety have not been fully evaluated. ...
Background and purpose: Buyang Huanwu decoction (BYHWD) is widely used in the treatment of ischemic stroke in the recovery period, an …
Role and molecular mechanism of traditional Chinese medicine in preventing cardiotoxicity associated with chemoradiotherapy.
Lv XF, Wen RQ, Liu K, Zhao XK, Pan CL, Gao X, Wu X, Zhi XD, Ren CZ, Chen QL, Lu WJ, Bai TY, Li YD. Lv XF, et al. Front Cardiovasc Med. 2022 Nov 7;9:1047700. doi: 10.3389/fcvm.2022.1047700. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36419486 Free PMC article. Review.
Angelica Sinensis, Astragalus membranaceus Bunge, Danshinone IIA sulfonate sodium (STS), Astragaloside (AS), Resveratrol, Ginsenoside, Quercetin, Danggui Buxue Decoction (DBD), Shengxian decoction (SXT), Compound Danshen Dripping Pill (CDDP), Qishen Huanwu Capsule (QSHWC), …
Angelica Sinensis, Astragalus membranaceus Bunge, Danshinone IIA sulfonate sodium (STS), Astragaloside (AS), Resveratrol, Ginsenoside, Querc …
Efficacy and Mechanism of Buyang Huanwu Decoction in Patients With Ischemic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial Combined With Proteomic Analysis.
Zhu M, Wei J, Li Y, Wang Y, Ren J, Li B, Ma B, Wang X, Qiao L, Zhou C, Liu J. Zhu M, et al. Front Pharmacol. 2022 Mar 18;13:831208. doi: 10.3389/fphar.2022.831208. eCollection 2022. Front Pharmacol. 2022. PMID: 35370712 Free PMC article.
Objective: Buyang Huanwu Decoction (BYHW), a famous herbal prescription in traditional Chinese medicine (TCM), has been used for 200 years for treating ischemic heart failure (IHF). ...
Objective: Buyang Huanwu Decoction (BYHW), a famous herbal prescription in traditional Chinese medicine (TCM), has been used for 200 …
Buyang huanwu decoction (BYHWD) alleviates sepsis-induced myocardial injury by suppressing local immune cell infiltration and skewing M2-macrophage polarization.
Xiao L, Xi X, Zhao M, Zhang L, Zhang K, Xu Z. Xiao L, et al. Am J Transl Res. 2023 Apr 15;15(4):2389-2406. eCollection 2023. Am J Transl Res. 2023. PMID: 37193167 Free PMC article.
OBJECTIVE: To investigate the therapeutic effect of Buyang huanwu decoction (BYHWD) on sepsis-induced myocardial injury (SIMI) and explore the mechanism by which BYHWD mitigates SIMI. ...
OBJECTIVE: To investigate the therapeutic effect of Buyang huanwu decoction (BYHWD) on sepsis-induced myocardial injury (SIMI) and ex …
[Study progress on chemical compounds, pharmacological action and clinical application of Naoxintong capsule].
Li WX, Zhang SQ, Zhao YD, Tang JF, Li CX, Wang XY, Li XL. Li WX, et al. Zhongguo Zhong Yao Za Zhi. 2018 May;43(10):1998-2005. doi: 10.19540/j.cnki.cjcmm.20180208.004. Zhongguo Zhong Yao Za Zhi. 2018. PMID: 29933662 Review. Chinese.
Naoxintong capsule (NXTC) is an oral Chinese preparation produced by modern technology, derived from the classic preparation of Buyang Huanwu decoction which was recorded by WANG Qing-ren (Qing dynasty) in Yilingaicuo Juanxia Tanweilun. ...
Naoxintong capsule (NXTC) is an oral Chinese preparation produced by modern technology, derived from the classic preparation of Buyang Hu …
Buyang Huanwu decoction increases angiopoietin-1 expression and promotes angiogenesis and functional outcome after focal cerebral ischemia.
Shen J, Zhu Y, Yu H, Fan ZX, Xiao F, Wu P, Zhang QH, Xiong XX, Pan JW, Zhan RY. Shen J, et al. J Zhejiang Univ Sci B. 2014 Mar;15(3):272-80. doi: 10.1631/jzus.B1300166. J Zhejiang Univ Sci B. 2014. PMID: 24599691 Free PMC article.
Buyang Huanwu decoction (BYHWD), a traditional Chinese herbal prescription, has been widely used clinically to treat stroke in China for hundreds of years; however, the mechanisms of this drug for stroke treatment are still unclear. ...
Buyang Huanwu decoction (BYHWD), a traditional Chinese herbal prescription, has been widely used clinically to treat stroke in China …
Buyang Huanwu Decoction promotes growth and differentiation of neural progenitor cells: using a serum pharmacological method.
Sun J, Bi Y, Guo L, Qi X, Zhang J, Li G, Tian G, Ren F, Li Z. Sun J, et al. J Ethnopharmacol. 2007 Sep 5;113(2):199-203. doi: 10.1016/j.jep.2007.05.018. Epub 2007 May 24. J Ethnopharmacol. 2007. PMID: 17692485
Buyang Huanwu Decoction (BYHWD), a traditional Chinese medicine, has been developed as a drug to be used for treatment of stroke for hundreds of years. ...
Buyang Huanwu Decoction (BYHWD), a traditional Chinese medicine, has been developed as a drug to be used for treatment of stroke for …
The effects of Buyang Huanwu Decoction on hemorheological disorders and energy metabolism in rats with coronary heart disease.
Wang WR, Lin R, Zhang H, Lin QQ, Yang LN, Zhang KF, Ren F. Wang WR, et al. J Ethnopharmacol. 2011 Sep 1;137(1):214-20. doi: 10.1016/j.jep.2011.05.008. Epub 2011 May 13. J Ethnopharmacol. 2011. PMID: 21605653
ETHNOPHARMACOLOGICAL RELEVANCE: Buyang Huanwu Decoction (BYHWD), a traditional Chinese medicine (TCM) formula, has been recognized as a clinical treatment for coronary heart disease (CHD) with qi deficiency and blood stasis syndrome. ...
ETHNOPHARMACOLOGICAL RELEVANCE: Buyang Huanwu Decoction (BYHWD), a traditional Chinese medicine (TCM) formula, has been recognized as …
Anti-angiogenic therapy for normalization of tumor vasculature: A potential effect of Buyang Huanwu decoction on nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential.
Min L, Ling W, Hua R, Qi H, Chen S, Wang H, Tang L, Shangguan W. Min L, et al. Mol Med Rep. 2016 Mar;13(3):2518-26. doi: 10.3892/mmr.2016.4854. Epub 2016 Feb 3. Mol Med Rep. 2016. PMID: 26846752 Free PMC article.
The present study aimed to investigate the effect of Buyang Huanwu decoction (BYHWD) on tumor growth, metastasis and angiogenesis in nude mice bearing human hepatocellular carcinoma (HCC) HCCLM3 xenografts. ...
The present study aimed to investigate the effect of Buyang Huanwu decoction (BYHWD) on tumor growth, metastasis and angiogenesis in …
16 results